drugset / Trial / NCT02258880

Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

NCT02258880 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of SUN13837 and to determine whether SUN13837 improves the physical performance, relative to placebo, following an acute stroke in adult subjects.

Timeline

Start
2014-09
Primary completion
2016-05
Completion
2016-05

Outcome

Outcome not reported

Stopped (Business): “study was stopped for business/administrative reasons and not for patient safety concerns”

Drugs

EvaluationDrugModalityDoseRoute
Subject SUN13837 Unknown — —

Indications